Clinical Trials Browser

Phase 2 × HER2 Positive Breast Cancer × Clear all

NCT03735966 2022-12-01

Neoadjuvant Study of Pyrotinib and Trastuzumab Plus Docetaxel and Carboplatin in HER2 Positive Breast Cancer Patients.

Phase 2 Completed

HER2 Positive Breast Cancer

NCT01904903 2022-05-10

SAFE-HEaRt

Phase 2 Completed

31 enrolled 12 charts

HER2 Positive Breast Cancer

NCT02362958 2020-07-15

A Multi-Center Study of Lapatinib in Patients With Trastuzumab-refractory Metastatic Breast Cancer

Phase 2 Completed

HER2 Positive Breast Cancer